Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Antithrombotic Therapy in Chronic Total Occlusion Interventions
Author(s): Iosif Xenogiannis , Charalampos Varlamos , Despoina-Rafailia Benetou , et al Added: 2 years ago

Intervention
Author(s): Steven V Manoukian , Michele D Voeltz , Frederick Feit Added: 3 years ago
Non-ST-segment elevation (NSTE) acute coronary syndromes (ACS) include unstable angina (UA) and NSTE myocardial infarction (NSTEMI), and account for 1.5 million hospitalizations in the US annually.1 Patients with ACS are typically managed by initial medical stabilization followed by an early invasive approach, whereby cardiac catheterization is performed, usually within 24 hours of admission… View more

MI/ACS
Author(s): Steven V Manoukian , Michele D Voeltz , Frederick Feit Added: 3 years ago
Non-ST-segment elevation (NSTE) acute coronary syndromes (ACS) include unstable angina (UA) and NSTE myocardial infarction (NSTEMI), and account for one and a half million hospitalisations in the US annually. Patients with ACS are typically managed by initial medical stabilisation followed by an early invasive approach, whereby cardiac catheterisation is performed, usually within 24 hours of… View more

Anticoagulation

MI/ACS
Author(s): Derek P Chew , Harvey D White Added: 3 years ago
Effective translation of reperfusion therapy to mortality reductions in ST-segment elevation myocardial infarction (STEMI) remains both time-critical in its implementation and dependent on optimal antithrombotic therapy. Innumerable clinical studies have explored several antithrombin and antiplatelet therapies in the immediate management of STEMI. With the wide array of the therapies now… View more

MI/ACS
Best Practices in Pharmacotherapy for Acute Coronary Syndromes
Author(s): Robert Barcelona Added: 1 year ago

Anticoagulation

MI/ACS
Antiplatelet and Anticoagulation Therapy in ACS
Author(s): Colin T Phillips , Michael C Gavin Added: 3 years ago
Acute coronary syndrome (ACS) occurs most often when a vulnerable intracoronary plaque ruptures or erodes to expose a prothrombotic core, precipitating thrombus formation by way of platelet activation,1–3 The spectrum of ACS includes non-ST segment-elevation (NSTE) ACS, where a vulnerable plaque threatens downstream coronary perfusion manifest as an increase in symptom frequency and/or duration … View more

Prevention & Chronic Conditions

MI/ACS
Author(s): Olivier F Bertrand , Tift Mann Added: 3 years ago
The highlights of the last decade in interventional cardiology have been the introduction of drug-eluting stents and an overall simplification of percutaneous coronary interventional procedures from a technological standpoint. Indeed, most interventions currently consist of either direct stenting or pre-dilatation followed by stent implantation; the use of rotational atherectomy and other niche… View more

Imaging & Diagnostics

Intervention
Stefan James
Job title: Professor of Cardiology
Prof Stefan James is Professor of Cardiology at Uppsala University, Scientific Director of Uppsala Clinical Research Center and a senior Interventional Cardiologist at Uppsala University Hospital in Sweden. He is the president of the Swedish society of Cardiology and a Fellow of the ESC.He graduated from Uppsala University Medical School and completed specialist training in Uppsala. He has… View more
View from the Thoraxcenter: AHA 22 Late-breaking Science Preview
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 1 year ago
In this dynamic late-breaking science preview Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) share their take on the most anticipated trials of the AHA Scientific Sessions. What late-breaking trials should we look out for? Which results are likely to impact your practice? What are the considerations and challenges? Trials covered in detail include: 37s:… View more

Standards & Guidelines

Heart Failure
ESC 23: The RIGHT Study
Author(s): Yan Yan , Gilles Montalescot Added: 7 months ago
ESC 23 — Dr Yan Yan (Beijing Anzhen Hospital, CN) and Prof Gilles Montalescot (Pitie Salpetriere APHP University Hospital,FR) discusses the findings from a comparison of anticoagulation prolongation vs no anticoagulation in STEMI patients post-primary PCI (RIGHT) (NCT03664180). The RIGHT study (Beijing Anzhen Hospital) aimed to evaluate the clinical efficacy and safety of anticoagulation… View more

Anticoagulation

MI/ACS